
Common name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
IUPAC name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
SMILES
C1(c2c(cccc2)-c3c1cccc3)[N](C)(C)CC
Common name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
IUPAC name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
SMILES
C1(c2c(cccc2)-c3c1cccc3)[N](C)(C)CC
INCHI
InChI=1S/C17H20N/c1-4-18(2,3)17-15-11-7-5-9-13(15)14-10-6-8-12-16(14)17/h5-12,17H,4H2,1-3H3
FORMULA
C17H20N

Common name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
IUPAC name
9-[ethyl(dimethyl)-λ4-azanyl]-9H-fluorene
Molecular weight
238.347
clogP
1.124
clogS
-5.373
Frequency
0.0003
HBond Acceptor
0
HBond Donor
0
Total PolarSurface Area
0
Number of Rings
3
Rotatable Bond
2
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD00796 | Hexafluronium |
![]() |
Neuromuscular Agents; Musculo-Skeletal System; Muscle Relaxants; Muscle Relaxants, Peripherally Acting Agents; | Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations. |
1 ,
1
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
2yki_ligand_1_1.mol2 | 2yki | 0.84058 | -8.68 | c1cccc2C(c3c(c12)cccc3)NC=O | 16 |
2ykc_ligand_1_0.mol2 | 2ykc | 0.84058 | -8.62 | c1ccc2c(c1)c1c(C2NC=O)cccc1 | 16 |
2ykb_ligand_1_0.mol2 | 2ykb | 0.84058 | -8.59 | c1ccc2c(c1)c1c(C2NC=O)cccc1 | 16 |
2ykj_ligand_1_1.mol2 | 2ykj | 0.84058 | -8.58 | N(C=O)C1c2ccccc2c2c1cccc2 | 16 |
1qiw_ligand_3_515.mol2 | 1qiw | 0.5 | -6.51 | CC[NH2+][C@H](C)c1ccccc1 | 11 |
2cgu_ligand_1_2.mol2 | 2cgu | 0.488636 | -8.23 | Oc1cc2c(c3c(cccc3)/C/2=N/O)cc1 | 16 |
3ccb_ligand.mol2 | 3ccb | 0.483871 | -7.51 | [NH3+]Cc1ccccc1c1ccccc1 | 15 |
4rlk_ligand.mol2 | 4rlk | 0.477778 | -10.09 | O=C(O)c1ccc(/C=N/N=C2c3ccccc3c3ccccc23)cc1 | 26 |
4rll_ligand.mol2 | 4rll | 0.477778 | -9.38 | O=C(O)c1ccc(/C=N/N=C2c3ccccc3c3ccccc23)cc1 | 26 |
2woa_ligand.mol2 | 2woa | 0.47191 | -9.10 | O[C@H](CC(=O)O)CCc1cc2Cc3ccccc3c2cc1 | 22 |
101 ,
11